 AGOURA HILLS, California, Feb. 16, 2021 GLOBE NEWSWIRE -- Mateon Therapeutics, Inc. OTCQB:MATN Mateon, a leading developer of TGF-β therapeutics for oncology and infectious disease and respiratory health, announced a global partnership with Chopra Foundation, a non-profit, to collaborate on research and development of PulmoHealTM and ARTIVedaTM for COVID-19 and other infectious diseases through joint research between Mateon and Foundation Principal Investigators PI from premium US universities. 